[1]高珍,彭广华.小分子化合物在干细胞诱导分化为视网膜色素上皮细胞中的应用[J].眼科新进展,2016,36(7):688-691.[doi:10.13389/j.cnki.rao.2016.0183]
　GAO Zhen,PENG Guang-Hua.Application of small molecule compounds in inducing differentiation of stem cells into retinal pigment epithelial cells[J].Recent Advances in Ophthalmology,2016,36(7):688-691.[doi:10.13389/j.cnki.rao.2016.0183]
点击复制

小分子化合物在干细胞诱导分化为视网膜色素上皮细胞中的应用
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
36卷
期数:
2016年7期
页码:
688-691
栏目:
文献综述
出版日期:
2016-07-05

文章信息/Info

Title:
Application of small molecule compounds in inducing differentiation of stem cells into retinal pigment epithelial cells
作者:
高珍; 彭广华
450052　河南省郑州市，郑州大学第一附属医院眼科
Author(s):
GAO Zhen; PENG Guang-Hua
Department of Ophthalmology, the First Affiliated Hospital of Zhengzhou University , Zhengzhou 450052 , Henan Province , China
关键词:
小分子化合物; 干细胞; 视网膜色素上皮细胞
Keywords:
small molecule compounds ;  stem cells ;  retinal pigment epithelial cells
分类号:
Ｒ７７４.１
DOI:
10.13389/j.cnki.rao.2016.0183
文献标志码:
A
摘要:
视网膜色素上皮细胞的变性、坏死将导致患者的视力丧失。由于视网膜色素上皮细胞不能再生，移植健康的视网膜色素上皮细胞已成为视网膜变性性疾病最具有前景的治疗策略。随着化学、分子生物学和再生医学的发展，人们发现越来越多的小分子化合物通过调控某些特定的信号通路，能够操纵干细胞的分化方向。本文主要对小分子化合物在体外诱导干细胞定向分化为视网膜色素上皮细胞的应用作一综述。
Abstract:
The degeneration and necrosis of retinal pigment epithelial( RPE) cells is the leading cause of vision loss in patients. Because the RPE cells cannot regenerate, healthy RPE cells transplantation has become the most promising strategies for the treatment of retinal degeneration diseases. With the development of chemistry,molecular biology and regenerative medicine .more and more small molecule compounds which manipulate stem cells differentiation by regulating the certain signaling pathways are discovered. This review reviews the applications of small molecule compounds in regulateing differentiation of stem cells into RPE cells in vitro.

相似文献/References:

[1]王娜 刘振山 冯云 陈银银 薛志刚 范国平.角膜内皮细胞体外培养的研究进展[J].眼科新进展,2013,33(6):000.
[2]冯云 刘振山 王娜 薛志刚 范国平.体外神经视网膜重构及退行性眼病的临床治疗展望[J].眼科新进展,2013,33(8):000.
[3]胡雅敏 罗敏 谷平.干细胞在视网膜损伤修复中的应用进展[J].眼科新进展,2013,33(2):000.
[4]李筱荣.干细胞在视网膜疾病中的应用研究进展[J].眼科新进展,2013,33(10):000.
[5]张青林,张旭.干细胞治疗青光眼的研究进展[J].眼科新进展,2017,37(9):886.[doi:10.13389/j.cnki.rao.2017.0225]
　ZHANG Qing-Lin,ZHANG Xu.Stem cells for the treatment of glaucoma[J].Recent Advances in Ophthalmology,2017,37(7):886.[doi:10.13389/j.cnki.rao.2017.0225]
[6]王霞,刘瀛,刘旭,等.诱导多功能干细胞在青光眼治疗中的应用研究进展[J].眼科新进展,2017,37(12):1185.[doi:10.13389/j.cnki.rao.2017.0299]
　WANG Xia,LIU Ying,LIU Xu,et al.Recent advances of induced pluripotent stem cells in glaucoma treatment[J].Recent Advances in Ophthalmology,2017,37(7):1185.[doi:10.13389/j.cnki.rao.2017.0299]
[7]于莎莎,赵云.干细胞对视神经损伤的修复作用[J].眼科新进展,2018,38(3):298.[doi:10.13389/j.cnki.rao.2018.0070]
　YU Sha-Sha,ZHAO Yun.Latest progress in stem cell transplantation for the treatment of optic nerve injury[J].Recent Advances in Ophthalmology,2018,38(7):298.[doi:10.13389/j.cnki.rao.2018.0070]
[8]李润璞,金鑫.基因组编辑技术在遗传性视网膜营养不良基因治疗和细胞治疗中的应用[J].眼科新进展,2020,40(3):290.[doi:10.13389/j.cnki.rao.2020.0068]
　LI Runpu,JIN Xin.Application of genomic editing technology in gene therapy and cell therapy of inherited retinal dystrophies[J].Recent Advances in Ophthalmology,2020,40(7):290.[doi:10.13389/j.cnki.rao.2020.0068]
[9]万光明,余川.重视不同来源移植细胞在视网膜退行性疾病中的替代治疗作用[J].眼科新进展,2022,42(8):589.[doi:10.13389/j.cnki.rao.2022.0121]
　WAN Guangming,YU Chuan.Effect of the replacement therapy of transplanted cells from different sources in retinal degenerative diseases[J].Recent Advances in Ophthalmology,2022,42(7):589.[doi:10.13389/j.cnki.rao.2022.0121]
[10]顾华香,程验,李鹏飞,等.干细胞在泪膜为导向型干眼治疗中作用的研究进展[J].眼科新进展,2023,43(11):903.[doi:10.13389/j.cnki.rao.2023.0181]
　GU Huaxiang,CHENG Yan,LI Pengfei,et al.Advances in the role of stem cells in tear film-oriented therapy for dry eye[J].Recent Advances in Ophthalmology,2023,43(7):903.[doi:10.13389/j.cnki.rao.2023.0181]

备注/Memo

备注/Memo:
国家重点基础研究发展计划（编号：２０１３ＣＢ９６７００１）；国家自然科学基金项目（编号：３１２７１４００、３１４７００６５）
更新日期/Last Update: 2016-07-12